Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Pembrolizumab is an anti-cancer drug that targets programmed cell death protein-1 (PD-1) receptors on lymphocytes resulting in their activation against tumour cells. PD-1 receptors are also interspersed in endocrine organs and pembrolizumab use has long been associated with hypophysitis and thyroidi...

Full description

Saved in:
Bibliographic Details
Published in:Clin Med (Lond)
Main Authors: Kyriacou, Angelos, Melson, Eka, Chen, Wentin, Kempegowda, Punith
Format: Artigo
Language:Inglês
Published: Royal College of Physicians 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7385772/
https://ncbi.nlm.nih.gov/pubmed/32675150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2020-0054
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items